What You Should Know:
-AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel approach to medicine, today announced that the Centers for Medicare and Medicaid Services (CMS) established a unique Healthcare Common Procedure Coding System (HCPCS) Level II code (E1905) for its flagship product, the RelieVRx program.
- Defined as a virtual reality (VR) cognitive behavioral therapy (CBT) device that includes pre-programmed therapy software, CMS’ coding decision categorizes the
Read More
AppliedVR
VA Provides Veterans with Immersive, VR Treatment for Chronic Lower Back Pain
What You Should Know:
- AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced a contract with the U.S. Department of Veterans Affairs (VA) to provide its FDA-authorized RelieVRx (formerly EaseVRx) solution to select Veterans impacted by chronic lower back pain (CLBP).
- AppliedVR was awarded the contract with the VHA Innovation Ecosystem, a division of the VA that discovers, evaluates, and
Read More
Techstars Relaunches Healthcare Accelerator in Los Angeles
What You Should Know:
- Techstars, a global investment business that provides access to capital, one-on-one mentorship, and customized programming for early-stage entrepreneurs announces today the relaunch of Techstars Healthcare sponsored by Cedars-Sinai, Point32Health, UCI Health, and UnitedHealthcare.
- The consortium-led accelerator program will be based in Los Angeles and select 12 high-growth startups to participate in its intensive 13-week program. Startups will receive capital,
Read More
Komodo Health & AppliedVR Partner to Drive Therapeutic VR for Chronic Pain
What You Should Know:
- Komodo Health, a company delivering patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems. today announced a new partnership with AppliedVR, the leader in therapeutic virtual reality (VR) for pain management.
- Using Komodo’s technology, AppliedVR will combine its proprietary insights with Komodo’s real-world data to conduct clinical research into the efficacy, cost savings, and health system
Read More
AppliedVR Awarded FDA Approval for VR Therapeutic for Lower Back Pain
What You Should Know:
- AppliedVR, an L.A.-based advancing the next generation of immersive therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted de novo approval for its flagship immersive therapeutic, EaseVRx, to treat chronic low back pain, which previously received breakthrough device designation in 2020. The news also comes on the heels of AppliedVR announcing its $36M series B funding round, bringing its total funding to $71M.
- Following
Read More
AppliedVR Secures $36M to Scale Therapeutic Virtual Reality Platform for Pain Management
What You Should Know:
- AppliedVR, a Los Angeles, CA-based company advancing the next generation of immersive therapeutics, today announced $36 million in series B funding, bringing its total funding to $71M. The round, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, set up AppliedVR for rapid growth as it prepares for its decision from the FDA on its first de novo submission.
- Virtual reality provides an immersive experience that
Read More
Curebase, AppliedVR Partner on Multiple VR Therapy Clinical Trials
What You Should Know:
- Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR) therapy to treat chronic pain.
- AppliedVR is the most evidence-based therapeutic VR platform for pain management and has been used by
Read More
AppliedVR Lands $29M for VR Platform to Treat Chronic Pain
What You Should Know:
- AppliedVR, a Los Angeles, CA-based company advancing the next generation of digital medicine, today announced $29 million in Series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.
- Founded in 2015, AppliedVR provides
Read More
FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment
What You Should Know:
- FDA awards AppliedVR Breakthrough Device designation for
treating treatment-resistant fibromyalgia and chronic intractable lower back
pain
- AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods.
AppliedVR,
a pioneer advancing the next generation of digital medicine, today announced
its EaseVRx product received Breakthrough Device designation
Read More
AppliedVR, NCI Partner to Evaluate VR As Therapy for Cancer-Related Anxiety
- AppliedVR announced a collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) to evaluate virtual reality (VR) as a solution to help address the underlying cancer-related anxiety. - The proof-of-concept study will evaluate AppliedVR’s virtual reality system on neuro-oncology patients’ “scanxiety,” a term used to describe the anxiety patients with cancer experience before or after medical diagnostics scans.AppliedVR, a Los Angeles, CA-based
Read More
